These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 15241294

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCI.
    Peters O, Lorenz D, Fesche A, Schmidtke K, Hüll M, Perneczky R, Rüther E, Möller HJ, Jessen F, Maier W, Kornhuber J, Jahn H, Luckhaus C, Gertz HJ, Schröder J, Pantel J, Teipel S, Wellek S, Frölich L, Heuser I.
    J Nutr Health Aging; 2012; 16(6):544-8. PubMed ID: 22659994
    [Abstract] [Full Text] [Related]

  • 23. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
    Nagakura A, Shitaka Y, Yarimizu J, Matsuoka N.
    Eur J Pharmacol; 2013 Mar 05; 703(1-3):53-61. PubMed ID: 23276665
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A molecular approach in drug development for Alzheimer's disease.
    Agatonovic-Kustrin S, Kettle C, Morton DW.
    Biomed Pharmacother; 2018 Oct 05; 106():553-565. PubMed ID: 29990843
    [Abstract] [Full Text] [Related]

  • 28. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease.
    Emre M, Mecocci P, Stender K.
    J Alzheimers Dis; 2008 Jun 05; 14(2):193-9. PubMed ID: 18560130
    [Abstract] [Full Text] [Related]

  • 29. TV 3326 for Alzheimer's dementia: a novel multimodal ChE and MAO inhibitors to mitigate Alzheimer's-like neuropathology.
    Uddin MS, Kabir MT, Rahman MM, Mathew B, Shah MA, Ashraf GM.
    J Pharm Pharmacol; 2020 Aug 05; 72(8):1001-1012. PubMed ID: 32149402
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM.
    CNS Drugs; 2002 Aug 05; 16(12):811-24. PubMed ID: 12421115
    [Abstract] [Full Text] [Related]

  • 32. [Pharmacotherapy for Alzheimer's disease].
    Verhey FR.
    Tijdschr Psychiatr; 2006 Aug 05; 48(1):17-26. PubMed ID: 16955982
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine.
    Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K.
    Expert Opin Drug Saf; 2014 Jun 05; 13(6):759-74. PubMed ID: 24845946
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Medical treatment of Alzheimer's disease].
    Johannsen P.
    Ugeskr Laeger; 2006 Oct 02; 168(40):3424-9. PubMed ID: 17032609
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease].
    Franke AG, Lieb K, Fellgiebel A.
    Fortschr Neurol Psychiatr; 2009 Jun 02; 77(6):326-33. PubMed ID: 19504422
    [Abstract] [Full Text] [Related]

  • 40. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN, Farlow MR, Grossberg GT, Graham SM, McDonald S, Gergel I, Memantine Study Group.
    JAMA; 2004 Jan 21; 291(3):317-24. PubMed ID: 14734594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.